ATE207489T1 - Benzimidazolderivate, deren herstellung und deren therapeutische anwendung - Google Patents

Benzimidazolderivate, deren herstellung und deren therapeutische anwendung

Info

Publication number
ATE207489T1
ATE207489T1 AT96303940T AT96303940T ATE207489T1 AT E207489 T1 ATE207489 T1 AT E207489T1 AT 96303940 T AT96303940 T AT 96303940T AT 96303940 T AT96303940 T AT 96303940T AT E207489 T1 ATE207489 T1 AT E207489T1
Authority
AT
Austria
Prior art keywords
ylmethyl
dioxothiazolidin
production
therapeutic use
benzimidazole derivatives
Prior art date
Application number
AT96303940T
Other languages
English (en)
Inventor
Takashi Fujita
Kunio Wada
Minoru Oguchi
Hiroaki Yanagisawa
Koichi Fujimoto
Toshihiko Fujiwara
Hiroyoshi Horikoshi
Takao Yoshioka
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26385935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE207489(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE207489T1 publication Critical patent/ATE207489T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96303940T 1995-06-01 1996-05-31 Benzimidazolderivate, deren herstellung und deren therapeutische anwendung ATE207489T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13509795 1995-06-01
JP4584596 1996-03-04

Publications (1)

Publication Number Publication Date
ATE207489T1 true ATE207489T1 (de) 2001-11-15

Family

ID=26385935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96303940T ATE207489T1 (de) 1995-06-01 1996-05-31 Benzimidazolderivate, deren herstellung und deren therapeutische anwendung

Country Status (20)

Country Link
US (1) US5886014A (de)
EP (1) EP0745600B1 (de)
JP (2) JP2976885B2 (de)
KR (2) KR100485425B1 (de)
CN (1) CN1066729C (de)
AT (1) ATE207489T1 (de)
AU (1) AU712390B2 (de)
CA (1) CA2177858C (de)
CZ (1) CZ293016B6 (de)
DE (1) DE69616151T2 (de)
DK (1) DK0745600T3 (de)
ES (1) ES2164841T3 (de)
HU (1) HU225778B1 (de)
IL (1) IL118474A (de)
MX (1) MX9602122A (de)
NO (1) NO308744B1 (de)
NZ (1) NZ286716A (de)
PT (1) PT745600E (de)
RU (1) RU2125048C1 (de)
TW (1) TW449594B (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925656A (en) * 1995-04-10 1999-07-20 Dr. Reddy's Research Foundation Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
EP0783888A1 (de) * 1995-12-26 1997-07-16 Sankyo Company Limited Verwendung von Troglitazone und verwandten Thiazolidinedionen zur Herstellung eines Medikaments für die Behandlung und Vorbeugung der Osteoporose
US6127367A (en) * 1996-02-29 2000-10-03 Pfizer, Inc. Method of reducing tissue damage associated with non-cardiac ischemia
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
ZA972152B (en) * 1996-03-18 1997-09-17 Sankyo Co Treatment and prophylaxis of pancreatitis.
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
CZ388598A3 (cs) * 1996-05-31 1999-07-14 Sankyo Company, Limited Léčivo proti autoimunní nemoci
CA2257284C (en) * 1996-05-31 2005-10-04 Sankyo Company Limited Remedy for autoimmune diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5985884A (en) * 1996-07-01 1999-11-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6011036A (en) * 1997-04-15 2000-01-04 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
AU2823797A (en) * 1997-05-02 1997-11-19 Dr. Reddy's Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
PT1022272E (pt) * 1997-10-08 2004-08-31 Sankyo Co Compostos heterociclicos fundidos substituidos
HUP9902721A2 (hu) * 1997-11-25 1999-12-28 The Procter & Gamble Co. Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
WO1999030739A1 (en) * 1997-12-16 1999-06-24 Sankyo Company, Limited Leukemia remedy
EP1132087A4 (de) * 1998-11-13 2002-06-26 Fujisawa Pharmaceutical Co Heilmittel gegen polyzystisches-eierstock-syndrom
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
AU3073600A (en) * 1999-01-19 2000-08-07 Sankyo Company Limited Inhibitor for nerve cell death due to glutamic acid cytotoxicity
KR20020060067A (ko) * 1999-04-06 2002-07-16 가와무라 요시부미 α-치환 카르복실산 유도체
ID30498A (id) * 1999-04-07 2001-12-13 Sankyo Co Senyawa-senyawa turunan amina
WO2000061582A1 (en) * 1999-04-08 2000-10-19 Sankyo Company, Limited Substituted fused imidazole derivatives
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
AU5570000A (en) 1999-06-28 2001-01-31 Sankyo Company Limited Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
JP2001072671A (ja) * 1999-06-28 2001-03-21 Sankyo Co Ltd ベンズイミダゾール化合物の合成中間体およびその製造方法
HUP0202340A3 (en) * 1999-07-19 2006-03-28 Sankyo Company Ltd Chuo Ku Pharmaceutical compositions containing condensed heterocyclic compounds as active ingredient and their use
AU7559200A (en) * 1999-10-12 2001-04-23 Japan Tobacco Inc. Hypertriglyceridemia remedies and antiobestics
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
JP2002088048A (ja) * 2000-07-13 2002-03-27 Sumitomo Chem Co Ltd Ｎ−ｔ−ブトキシカルボニルニトロアニリン誘導体の製造法
EP1172356B1 (de) 2000-07-13 2004-10-06 Sumitomo Chemical Company, Limited Verfahren zur Herstellung von N-Acylnitroanilinderivaten
RU2205826C2 (ru) * 2000-12-21 2003-06-10 Национальная фармацевтическая академия Украины (±)-цис-3-(2'-бензимидазолил)-1,2,2-триметилциклопентанкарбоновая кислота, проявляющая сахароснижающее и антидиабетогенное действие
US6452014B1 (en) * 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
EP1354602B1 (de) * 2000-12-26 2006-10-04 Sankyo Company, Limited Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel
GB0112363D0 (en) 2001-05-21 2001-07-11 Allied Therapeutics Ltd Method and apparatus for treating biological fluids
FR2829765A1 (fr) * 2001-09-14 2003-03-21 Lipha Derives imidazolylalkoxylarylalcanoiques leurs applications en therapeutique
CN100427609C (zh) 2001-10-24 2008-10-22 加利福尼亚大学董事会 鉴定5-脂氧化酶作为引起动脉硬化症的主要基因
US20050119314A1 (en) * 2002-04-05 2005-06-02 Sankyo Company, Limited Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
JP2004002365A (ja) * 2002-04-05 2004-01-08 Sankyo Co Ltd Ａｃａｔ阻害剤とインシュリン抵抗性改善剤とからなる医薬組成物
EP1493448A4 (de) * 2002-04-05 2007-12-05 Sankyo Co Medizinische zusammensetzung mit acat-hemmer und mittel zur verbesserung der insulinresistenz
WO2004000356A1 (ja) * 2002-06-25 2003-12-31 Sankyo Company, Limited 利尿剤及びペルオキシソーム増殖因子活性化受容体（PPAR)γ活性化剤を含有する医薬組成物
JP2004083574A (ja) * 2002-06-25 2004-03-18 Sankyo Co Ltd 利尿剤及びペルオキシソーム増殖因子活性化受容体（ＰＰＡＲ）γ活性化剤を含有する医薬組成物
AU2003254795A1 (en) * 2002-08-02 2004-02-23 Sankyo Company, Limited Resorcinol derivative
US7232828B2 (en) * 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
WO2004035830A1 (ja) * 2002-10-18 2004-04-29 Sankyo Company,Limited β細胞機能不全改善剤の評価方法
US20040198800A1 (en) * 2002-12-19 2004-10-07 Geoffrey Allan Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
DE602004030470D1 (de) * 2003-10-24 2011-01-20 Santen Pharmaceutical Co Ltd Therapeutisches mittel für keratokonjunktive erkrankungen
CA2543555A1 (en) 2003-10-29 2005-05-06 Santen Pharmaceutical Co., Ltd. Therapeutic agent for keratoconjunctival disorder
WO2005092382A1 (ja) * 2004-03-29 2005-10-06 Sankyo Company, Limited インスリン抵抗性改善剤を含有する糖尿病治療剤
RU2246945C1 (ru) * 2004-05-11 2005-02-27 Аверин Константин Михайлович Суппозитории притововоспалительного, антисептического и регенерационного действия
TW200608967A (en) * 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
WO2006022450A1 (ja) * 2004-08-26 2006-03-02 Santen Pharmaceutical Co., Ltd. 皮膚疾患治療剤
US7816552B2 (en) 2004-09-28 2010-10-19 Sankyo Company, Limited Intermediate of 6-substituted 1-methyl-1-H-benzimidazole derivative and method for producing same
JP4789180B2 (ja) * 2004-09-28 2011-10-12 第一三共株式会社 ６−置換−１−メチル−１−ｈ−ベンズイミダゾール誘導体の製造方法及びその製造中間体
US20060106014A1 (en) * 2004-10-14 2006-05-18 Sekhar Boddupalli Methods for treating diabetes
CA2585030A1 (en) * 2004-10-27 2006-05-04 F. Hoffmann-La Roche Ag New indole or benzimidazole derivatives
EP1825854A1 (de) * 2004-12-15 2007-08-29 Daiichi Sankyo Company, Limited EINEN FBPase INHIBITOR ENTHALTENDE MEDIZINISCHE ZUSAMMENSETZUNG
TW200637856A (en) * 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
JP2006225382A (ja) * 2005-01-24 2006-08-31 Sankyo Co Ltd チアゾリジンジオン化合物の製造方法及びその製造中間体
TW200722088A (en) * 2005-05-27 2007-06-16 Sankyo Co Diabetes remedy
TWI418350B (zh) * 2005-06-24 2013-12-11 Sankyo Co 含有ｐｐａｒ調節劑之醫藥組成物的用途
JPWO2007007656A1 (ja) * 2005-07-08 2009-01-29 第一三共株式会社 チアゾリジンジオン化合物を含有する医薬組成物
CN101272805A (zh) * 2005-07-12 2008-09-24 第一三共株式会社 包含PPARγ激动剂的药物组合物
TW200738266A (en) * 2005-09-29 2007-10-16 Sankyo Co Pharmaceutical agent containing insulin resistance improving agent
TW200730173A (en) * 2005-12-16 2007-08-16 Sankyo Co Pharmaceutical composition enhancing production of adiponectin
JP2008044932A (ja) * 2006-07-21 2008-02-28 Daiichi Sankyo Co Ltd チアゾリジンジオン化合物を含有する組成物
CA2662084A1 (en) 2006-09-07 2008-03-13 Nycomed Gmbh Combination treatment for diabetes mellitus
KR100811100B1 (ko) * 2006-09-27 2008-03-06 한국생명공학연구원 벤즈아졸 유도체를 유효성분으로 함유하는 대사성 질환예방 및 치료용 약학적 조성물
BRPI0809643A2 (pt) * 2007-04-05 2014-11-11 Daiichi Sankyo Co Ltd Derivados de heteroarila bicíclica fundida
AU2008259342B2 (en) 2007-06-04 2014-07-10 Ben-Gurion University Of The Negev Research And Development Authority Tri-aryl compounds and compositions comprising the same
KR20100137417A (ko) 2008-02-25 2010-12-30 산텐 세이야꾸 가부시키가이샤 각막 상피 배리어 기능 항진제
CA2781800A1 (en) 2009-11-26 2011-06-03 Daiichi Sankyo Company, Limited Method for manufacturing a 6-substituted 1-methyl-1h-benzimidazole derivative and an intermediate of said method
US8859780B2 (en) * 2011-12-28 2014-10-14 Allergan, Inc. Benzimidazole derivatives as selective blockers of persistent sodium current
WO2015068156A1 (en) 2013-11-05 2015-05-14 Ben-Gurion University Of The Negev Research And Development Authority Compounds for the treatment of diabetes and disease complications arising from same
CN104083364B (zh) * 2014-07-18 2015-12-09 泰山医学院附属医院 一种治疗阴沟肠杆菌引起的小儿呼吸道感染的药物组合物
CN104086541B (zh) * 2014-07-18 2016-01-20 高中设 一种治疗小儿呼吸道感染的药物组合物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPS60226873A (ja) * 1984-03-28 1985-11-12 Sankyo Co Ltd １，３−ベンゾオキサチオ−ル誘導体及びその製法
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
DK173350B1 (da) * 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
EP0842925A1 (de) * 1987-09-04 1998-05-20 Beecham Group Plc Substituierte Thiazolidindionderivate
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JP2826379B2 (ja) * 1990-01-22 1998-11-18 三共株式会社 チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
EP0454501B1 (de) * 1990-04-27 2001-09-05 Sankyo Company Limited Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
DK0544696T3 (da) * 1990-08-23 1995-06-06 Pfizer Hypoglycæmiske hydroxyurinstofderivater
GB9023585D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
RU2066322C1 (ru) * 1991-06-28 1996-09-10 Киевский Государственный Университет Им.Т.Г.Шевченко 3-(4-метил-2-тиазолил)-6-пропил-7-(1-метил-1-этоксикарбонил)метоксихромон, обладающий гипогликемическим, гиполипидемическим действием и аналептическим действием
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
US5614544A (en) * 1993-09-14 1997-03-25 Takeda Chemical Industries, Ltd. Oxazolidinedione derivatives and their use
CA2145257A1 (en) * 1994-03-23 1995-09-24 Takashi Fujita Thiazolidine and oxazolidine derivatives, their preparation and their medical use
RU2151145C1 (ru) * 1994-04-11 2000-06-20 Санкио Компани Лимитед Промежуточное соединение для получения гетероциклических соединений, обладающих антидиабетической активностью
US5420146A (en) * 1994-05-10 1995-05-30 American Home Products Corporation Di-oxadiazolidine derivatives as antihyperglycemic agents
JPH08143556A (ja) * 1994-11-15 1996-06-04 Terumo Corp ジオキソチアゾリジン誘導体及びそれを含有する医薬組成物
JPH08143568A (ja) * 1994-11-22 1996-06-04 Terumo Corp ピリドピリミジン誘導体及びそれを含有する医薬組成物
JPH08143566A (ja) * 1994-11-25 1996-06-04 Terumo Corp キナゾリン誘導体及びそれを含有する医薬組成物
JP3929512B2 (ja) * 1995-06-02 2007-06-13 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法

Also Published As

Publication number Publication date
KR970001349A (ko) 1997-01-24
NO962239D0 (no) 1996-05-31
HUP9601492A2 (hu) 1998-08-28
HK1002280A1 (en) 1998-08-14
KR100485425B1 (ko) 2005-10-27
CA2177858C (en) 2010-07-06
EP0745600B1 (de) 2001-10-24
ES2164841T3 (es) 2002-03-01
HU225778B1 (en) 2007-08-28
NZ286716A (en) 1997-08-22
AU712390B2 (en) 1999-11-04
PT745600E (pt) 2002-02-28
JP2976885B2 (ja) 1999-11-10
MX9602122A (es) 1997-06-28
CA2177858A1 (en) 1996-12-02
EP0745600A1 (de) 1996-12-04
HUP9601492A3 (en) 1998-10-28
CZ156796A3 (en) 1996-12-11
IL118474A0 (en) 1996-09-12
DE69616151D1 (de) 2001-11-29
CZ293016B6 (cs) 2004-01-14
DK0745600T3 (da) 2001-11-12
JP3249490B2 (ja) 2002-01-21
CN1157288A (zh) 1997-08-20
KR100493772B1 (ko) 2005-06-08
TW449594B (en) 2001-08-11
HU9601492D0 (en) 1996-07-29
CN1066729C (zh) 2001-06-06
JP2000001487A (ja) 2000-01-07
NO308744B1 (no) 2000-10-23
AU5462796A (en) 1996-12-12
NO962239L (no) 1996-12-02
JPH09295970A (ja) 1997-11-18
IL118474A (en) 2001-08-08
DE69616151T2 (de) 2002-07-11
RU2125048C1 (ru) 1999-01-20
HK1011683A1 (en) 1999-07-16
US5886014A (en) 1999-03-23

Similar Documents

Publication Publication Date Title
ATE207489T1 (de) Benzimidazolderivate, deren herstellung und deren therapeutische anwendung
ATE177088T1 (de) Oxim-derivate, deren herstellung und deren therapeutische anwendung
ATE143002T1 (de) Aromatische aminoalkoholderivate mit antidiabetischer und antiobesitäts-wirkung, ihre herstellung und therapeutische verwendung
NO970892L (no) Isoksazolderivater
ATE67496T1 (de) Thiazolidinderivate, verfahren zu deren herstellung und deren anwendung.
ATE175676T1 (de) Propiophenon-derivate und verfahren zur ihrer herstellung
ATE158795T1 (de) Thiazolidindionderivate, ihre herstellung und anwendung
NO981204D0 (no) Selektive <beta>3 -adrenergiske agonister
ATE181067T1 (de) Benzothiazol-derivate, verfahren zur herstellung sowie anwendungen